CGPHF (Grand Pharmaceutical Group) Interest Coverage: 8.44 (As of Dec. 2025) — 25% Below Median


What is Grand Pharmaceutical Group Interest Coverage?

Grand Pharmaceutical Group CGPHF 87 Interest Coverage is 8.44 as of Dec. 2025, which is 25% below its 10-year median of 11.21. GuruFocus rates CGPHF with a GF Score™ of 87/100. The stock has 6 warning signs investors should review. Among 685 Drug Manufacturers companies, Grand Pharmaceutical Group ranks worse than 53.87% on this metric.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Grand Pharmaceutical Group's Operating Income for the six months ended in Dec. 2025 was $88.92 Mil. Grand Pharmaceutical Group's Interest Expense for the six months ended in Dec. 2025 was $-10.54 Mil. Grand Pharmaceutical Group's interest coverage for the quarter that ended in Dec. 2025 was 8.44. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for Grand Pharmaceutical Group's Interest Coverage or its related term are showing as below:

CGPHF' s Interest Coverage Range Over the Past 10 Years
Min: 2.37   Med: 11.21   Max: 21.67
Current: 10.37

CGPHF's Interest Coverage is ranked worse than
53.87% of 685 companies
in the Drug Manufacturers industry
Industry Median: 12.78 vs CGPHF: 10.37

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Grand Pharmaceutical Group  (OTCPK:CGPHF) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .

Grand Pharmaceutical Group Interest Coverage Related Terms

Grand Pharmaceutical Group Interest Coverage Historical Data

* Premium members only.

The historical data trend for Grand Pharmaceutical Group's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Grand Pharmaceutical Group Interest Coverage Chart

Grand Pharmaceutical Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Interest Coverage
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.67 19.52 13.76 12.05 10.37

Grand Pharmaceutical Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.02 15.94 8.49 12.35 8.44

CGPHF vs ZTS: Interest Coverage Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Grand Pharmaceutical Group's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Grand Pharmaceutical Group Interest Coverage vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Grand Pharmaceutical Group's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Grand Pharmaceutical Group's Interest Coverage falls into.


Grand Pharmaceutical Group Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Grand Pharmaceutical Group's Interest Coverage for the fiscal year that ended in Dec. 2025 is calculated as

Here, for the fiscal year that ended in Dec. 2025, Grand Pharmaceutical Group's Interest Expense was $-20.86 Mil. Its Operating Income was $216.43 Mil. And its Long-Term Debt & Capital Lease Obligation was $241.75 Mil.

Interest Coverage=-1* Operating Income (A: Dec. 2025 )/Interest Expense (A: Dec. 2025 )
=-1*216.426/-20.864
=10.37

Grand Pharmaceutical Group's Interest Coverage for the quarter that ended in Dec. 2025 is calculated as

Here, for the six months ended in Dec. 2025, Grand Pharmaceutical Group's Interest Expense was $-10.54 Mil. Its Operating Income was $88.92 Mil. And its Long-Term Debt & Capital Lease Obligation was $241.75 Mil.

Interest Coverage=-1* Operating Income (Q: Dec. 2025 )/Interest Expense (Q: Dec. 2025 )
=-1*88.916/-10.537
=8.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.

Frequently Asked Questions Learn more about Interest Coverage →
What does a Interest Coverage of 8.44 mean?
Grand Pharmaceutical Group (CGPHF) has a Interest Coverage of 8.44 as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Grand Pharmaceutical Group and its competitors. This is 25% below median its historical median of 11.21. Over the past decade, Grand Pharmaceutical Group's Interest Coverage has ranged from 2.37 to 21.67. According to the industry distribution chart, Grand Pharmaceutical Group ranks #369 out of 685 companies in the Drug Manufacturers industry, placing it in the top 53.9%.
Is Grand Pharmaceutical Group's Interest Coverage too high?
Grand Pharmaceutical Group's current Interest Coverage of 8.44 is 25% below median its 10-year median of 11.21. Over the past 10 years, this metric has ranged from a low of 2.37 to a high of 21.67. The Drug Manufacturers industry median Interest Coverage is 12.78. Grand Pharmaceutical Group's value of 8.44 is 34% below this industry median. Based on the distribution chart, Grand Pharmaceutical Group ranks #369 out of 685 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Grand Pharmaceutical Group has a GF Score™ of 87/100, reflecting its overall financial health beyond just this single metric.
How does Grand Pharmaceutical Group's Interest Coverage compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Grand Pharmaceutical Group ranks #369 out of 685 companies for Interest Coverage. This places Grand Pharmaceutical Group in the lower half of its industry. The industry median Interest Coverage is 12.78. Grand Pharmaceutical Group's value of 8.44 is 34% below this benchmark. Historically, Grand Pharmaceutical Group's own Interest Coverage has ranged from 2.37 to 21.67 over the past decade. While the company's 10-year median is 11.21 vs. the industry median of 12.78, Grand Pharmaceutical Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.78, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Grand Pharmaceutical Group's current Interest Coverage of 8.44 is 34% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Grand Pharmaceutical Group and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Grand Pharmaceutical Group's current Interest Coverage is 8.44, which is 25% below median its own 10-year median of 11.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grand Pharmaceutical Group stock overvalued right now?
Grand Pharmaceutical Group (CGPHF) has a current Interest Coverage of 8.44. The current Interest Coverage is 8.44, which is 25% below median its 10-year median of 11.21 and 34% below the Drug Manufacturers industry median of 12.78. Grand Pharmaceutical Group's overall GF Score™ is 87/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Grand Pharmaceutical Group (CGPHF), the current Interest Coverage is 8.44 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Grand Pharmaceutical Group Business Description

Other Exchanges 00512:Hong KongMX6A:Germany
Address 99 Queen\'s Road Central, Units 3302, 33rd Floor, The Center, Hong Kong, HKG
Grand Pharmaceutical Group Ltd are principally engaged in the manufacture and sales of pharmaceutical technology products, manufacture and sales of bio-technology products as well as manufacture and sales of nuclear medicine anti-tumor diagnosis and treatment and cerebro-cardiovascular precision interventional diagnosis and treatment technology products, in the People's Republic of China. The operation of the group constitutes one single reportable segment. The company has presence in The PRC, America, Europe, Asia other than the PRC and Others. The majority of revenue comes from the PRC. Its brands are breathe, biology, Cardiovascular emergency care, Cardiovascular intervention, ENT, tumor.